SMMT250117P20000
- 4.38
- +0.74+20.33%
Summit Therapeutics Newsroom
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
US MOVERS&SHAKERS Sep 23-Sep 27, 2024
Top Gap Ups and Downs on Friday: NVO, TM, INFY and More
Citi Downgrades Summit Therapeutics(SMMT.US) to Hold Rating, Raises Target Price to $23
Summit Therapeutics Downgraded to Neutral From Buy at Citi
Is Summit Therapeutics Inc. (SMMT) the Best Performing Stock in 2024?
Summit Therapeutics Analyst Ratings
Stifel Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Raises Target Price to $40
S&P 500 Futures Steady In Premarket Trading; KB Home, Liberty Broadband Lag
Stifel Nicolaus Sticks to Its Buy Rating for Summit Therapeutics (SMMT)
Express News | Summit Therapeutics Inc : Stifel Raises Target Price to $40 From $25
Summit Therapeutics, Intel Stir Monday's Afternoon Market Cap Stock Movers
Trending Stocks Today | Kaival Brands Innovations Surges 139.96%
This US Stock Is Crushing Nvidia's Performance This Year: Is It Too Late to Buy?
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
US MOVERS&SHAKERS Sep 16-Sep 20, 2024
Sector Update: Health Care Stocks Rise Premarket Friday
Express News | Summit Therapeutics Inc Files for Offering of 10.4 Mln Shares of Common Stock by Selling Stockholder - SEC Filing
BioNTech Is More Than a Covid-19 Stock. It's Having a Great September. -- Barrons.com
Is It Too Late to Buy Summit Therapeutics Stock After Its Almost 10X Gain This Year?